Discover 135 paid clinical trials in Wichita, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 135
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Sex: All
Age: 12+
Code: NCT07159763
Phase 3, Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: Newton KS, El Dorado KS, Lenexa KS, Oklahoma City OK,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase 3, Recruiting
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
for
Type 2 Diabetes
Location: El Dorado KS, Norfolk NE, McKinney TX, Lewisville TX,
Sponsor: Housey Healthcare ULC
Sex: All
Age: 18+
Code: NCT07546929
Phase 2, Recruiting
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
for
Asthma
Location: Hutchinson KS, Grand Island NE, Omaha NE, Greenville TX,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06932263
Phase 2, Recruiting
Prospective Study to Assess a Diagnostic Aid for Cancer
for
Cancer
Location: Hutchinson KS, Oklahoma City OK, Kansas City MO,
Sponsor: Harbinger Health
Sex: All
Age: 45+
Code: NCT07046260
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
for
Ulcerative Colitis, Crohn's Disease
Location: Hutchinson KS, Kansas City MO, Columbia MO,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06581328
Phase 4, Recruiting
Active & Responsive
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
for
Diabetes Mellitus, Type 2
Location: Newton KS, Topeka KS, Amarillo TX, West Des Moines IA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07817251
Phase 3, Recruiting
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
for
Early-stage Breast Cancer,
Location: Wichita KS, Fullerton CA, Whittier CA, Los Alamitos CA,
Sponsor: Jonsson Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT04553770
Phase 2, Recruiting
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
for
Aortic Stenosis
Location: Wichita KS, Oklahoma City OK, Kansas City KS,
Sponsor: Medtronic Cardiovascular
Sex: All
Age: 18 - 70+
Code: NCT06777368
Recruiting
Prevail Global Study
for
Coronary Artery Disease
Location: Wichita KS, Overland Park KS, Kansas City KS,
Sponsor: Medtronic Vascular
Sex: All
Age: 18+
Code: NCT06535854
Recruiting
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
for
Abdominal Aortic Aneurysm,
Location: Wichita KS, Plano TX, Denver CO, Rochester MN,
Sponsor: Medtronic Cardiovascular
Sex: All
Age: 20+
Code: NCT05378347
Recruiting
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Wichita KS, Omaha NE, St Louis MO, Lisle IL,
Sponsor: Syncromune, Inc.
Sex: Male
Age: 18+
Code: NCT06533644
Phase 2, Recruiting
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
for
Neurogenic Detrusor Overactivity
Location: Wichita KS, Oklahoma City OK, Little Rock AR, Aurora CO,
Sponsor: Urovant Sciences GmbH
Sex: All
Age: 2 - 17
Code: NCT05491525
Phase 2, Phase 3, Recruiting
Outcomes of Degenerative Disc Disease Patients Treated With an Anterior-Only Fusion Using InQu Bone Graft
for
Degenerative Disc Disease
Location: Wichita KS
Sponsor: Kansas Joint and Spine Institute
Sex: All
Age: 18 - 70
Code: NCT01746212
Recruiting
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
for
Healthy Volunteers, Influenza
Location: Newton KS, Oak Brook IL, Knoxville TN, Decatur GA,